Cavassini M - Search Results

1

Privacy-preserving genomic testing in the clinic: a model using HIV treatment.

McLaren PJ, Raisaro JL, Aouri M, Rotger M, Ayday E, Bartha I, Delgado MB, Vallet Y, Günthard HF, Cavassini M, Furrer H, Doco-Lecompte T, Marzolini C, Schmid P, Di Benedetto C, Decosterd LA, Fellay J, Hubaux JP, Telenti A. McLaren PJ, et al. Among authors: cavassini m. Genet Med. 2016 Aug;18(8):814-22. doi: 10.1038/gim.2015.167. Epub 2016 Jan 14. Genet Med. 2016. PMID: 26765343 Free PMC article.

2

Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study.

Zellweger C, Opravil M, Bernasconi E, Cavassini M, Bucher HC, Schiffer V, Wagels T, Flepp M, Rickenbach M, Furrer H; Swiss HIV Cohort Study. Zellweger C, et al. Among authors: cavassini m. AIDS. 2004 Oct 21;18(15):2047-53. doi: 10.1097/00002030-200410210-00009. AIDS. 2004. PMID: 15577626

3

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study. Kaufmann GR, et al. Among authors: cavassini m. Clin Infect Dis. 2005 Aug 1;41(3):361-72. doi: 10.1086/431484. Epub 2005 Jun 24. Clin Infect Dis. 2005. PMID: 16007534 Free article.

4

Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir.

Karrer U, Ledergerber B, Furrer H, Elzi L, Battegay M, Cavassini M, Gayet-Ageron A, Hirschel B, Schmid P, Russotti M, Weber R, Speck RF; Swiss HIV Cohort Study. Karrer U, et al. Among authors: cavassini m. AIDS. 2005 Nov 18;19(17):1987-94. doi: 10.1097/01.aids.0000194136.73876.9c. AIDS. 2005. PMID: 16260905

5

Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.

Glass TR, De Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, Bucher HC. Glass TR, et al. Among authors: cavassini m. J Acquir Immune Defic Syndr. 2006 Mar;41(3):385-92. doi: 10.1097/01.qai.0000186371.95301.52. J Acquir Immune Defic Syndr. 2006. PMID: 16540942

6

Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.

Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H; Swiss HIV Cohort Study. Elzi L, et al. Among authors: cavassini m. Clin Infect Dis. 2007 Jan 1;44(1):94-102. doi: 10.1086/510080. Epub 2006 Nov 28. Clin Infect Dis. 2007. PMID: 17143823 Free article.

7

Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.

Wunder DM, Bersinger NA, Fux CA, Mueller NJ, Hirschel B, Cavassini M, Elzi L, Schmid P, Bernasconi E, Mueller B, Furrer H; Swiss HIV Cohort Study. Wunder DM, et al. Among authors: cavassini m. Antivir Ther. 2007;12(2):261-5. Antivir Ther. 2007. PMID: 17503668

8

Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.

Glass TR, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, Bucher HC; Swiss HIV Cohort Study. Glass TR, et al. Among authors: cavassini m. HIV Clin Trials. 2007 Mar-Apr;8(2):77-85. doi: 10.1310/hct0802-77. HIV Clin Trials. 2007. PMID: 17507323

9

Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.

Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Egger M, Weber R; Swiss HIV Cohort Study. Ledergerber B, et al. Among authors: cavassini m. Clin Infect Dis. 2007 Jul 1;45(1):111-9. doi: 10.1086/518619. Epub 2007 May 21. Clin Infect Dis. 2007. PMID: 17554711 Free article.

10

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.

Wolbers M, Battegay M, Hirschel B, Furrer H, Cavassini M, Hasse B, Vernazza PL, Bernasconi E, Kaufmann G, Bucher HC; Swiss HIV Cohort Study. Wolbers M, et al. Among authors: cavassini m. Antivir Ther. 2007;12(6):889-97. Antivir Ther. 2007. PMID: 17926643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

708 results

Search Page

Filters